India's 1st homegrown mRNA Covid vax may have low market penetration: Report

The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab ...

Related Keywords

India ,New Delhi ,Delhi ,Neha Myneni ,Moderna Spikevax ,National Technical Advisory Group On Immunisation ,Pune Based Gennova Biopharmaceutical ,Drugs Controller General ,Pharma Analyst ,While Moderna ,National Technical Advisory Group ,